Compare Fortive Corporation Common Stock (FTV) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fortive Corporation Common Stock vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Fortive Corporation Common Stock trades at $56.51 (market cap $17.07B), while Halozyme Therapeutics Inc. Common Stock trades at $109.67 (market cap $12.58B). The key difference: Fortive Corporation Common Stock is the larger of the two by market cap, and Fortive Corporation Common Stock pays a 0.5% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Fortive Corporation Common Stock for 0 Days and Halozyme Therapeutics Inc. Common Stock for 0 Days on average.
| FTV | HALO | |
|---|---|---|
Market Cap | $17.07B | $12.58B |
Volume | 1,773,097 | 2,179,278 |
Sector | Technology | Health |
52-Week High | $64.09 | $115.22 |
52-Week Low | $47.80 | $61.63 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $20.21B | $14.49B |
Dividend Yield | 0.5% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Fortive Corporation Common Stock
Fortive provides industrial and healthcare technology solutions. Its products and software support measurement, maintenance, worker safety, instrument sterilization, and clinical workflows.
Read more on FTV →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
